1 pharmaceutical company settles ahead of San Francisco opioid trial | Region

SAN FRANCISCO (AP) — Drugmaker Endo Pharmaceuticals has agreed to pay the city of San Francisco $10 million for its role in selling prescription opioids in the city.

City Attorney David Chiu announced the settlement Wednesday, five days before the start of the trial of the city’s claims against the drug industry over the opioid toll.

Chiu said Endo, the maker of the prescription painkiller Percocet, was to pay $5 million this year and another $5 million over the next decade, with the money used to fight the coronavirus epidemic. opioids.

The Malvern, Pa.-based company has agreed to nearly $300 million in opioid claim settlements with U.S. government entities since 2019, according to an Associated Press tally. One of them, for $25 million, came this week with Alabama; this was announced with approximately $250 million in deals between the state and other companies.

A spokesperson for Endo did not immediately respond to requests for comment from The Associated Press.

The San Francisco lawsuit is set to open in U.S. District Court on Monday with claims involving drugmakers Allergan and Teva, distribution company Anda and drugstore chain Walgreens.

He is part of the first wave of federal cases chosen for trial.

Opioid trials are currently taking place in state courts in Florida and West Virginia. Closing arguments in a Washington state case scheduled for this month were recently moved to July. And the parties are awaiting a judge’s decision in another West Virginia trial held last year.

Prescription and illicit opioid overdoses have been linked to more than 500,000 deaths in the United States over the past two decades.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Elna M. Lemons